SCHEMBL14976356

SCHEMBL14976356

Cc1cc(Cl)c(NC2=NCCN2)c(Cl)c1C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CFB P00751 4/20 0.67
ADRA2C P18825 7/20 0.60
ADRA2A P08913 6/20 0.60
ADRA2B P18089 6/20 0.60
HTR1D P28221 5/20 0.60
HTR1B P28222 4/20 0.60
ADRA1A P35348 4/20 0.60
ADRA1D P25100 3/20 0.60
ADRA1B P35368 3/20 0.60
CYP2D6 P10635 3/20 0.60
NISCH Q9Y2I1 2/20 0.60
TSHR P16473 2/20 0.60
NFKB1 P19838 2/20 0.60
CYP1A2 P05177 1/20 0.60
HSD17B10 Q99714 1/20 0.60
LMNA P02545 4/20 0.58
BLM P54132 3/20 0.58
HIF1A Q16665 2/20 0.55
MEN1 O00255 1/20 0.55
SLC22A1 O15245 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24658874 0.81 ADRA2A (0.71) CFBADRA2CADRA2AADRA2BHTR1D
SCHEMBL6054563 0.78 ADRA2A (0.63) CFBADRA2CADRA2AADRA2BHTR1D
SCHEMBL11180812 0.78 ADRA2A (0.76) CFBADRA2CADRA2AADRA2BHTR1D
SCHEMBL1369069 0.78 ADRA2C (0.61) CFBADRA2CADRA2AADRA2BHTR1D
SCHEMBL11761437 0.75 ADRA2C (0.71) CFBADRA2CADRA2AADRA2BHTR1D
SCHEMBL10414088 0.75 ADRA2A (0.71) CFBADRA2CADRA2AADRA2BHTR1D
Pi-Clonidine SCHEMBL563884 0.75 ADRA2A (1.00) CFBADRA2CADRA2AADRA2BHTR1D
Apraclonidine SCHEMBL34128 0.75 ADRA2A (1.00) CFBADRA2CADRA2AADRA2BHTR1D
SCHEMBL6054523 0.75 ADRA2A (0.63) CFBADRA2CADRA2AADRA2BHTR1D
SCHEMBL11176814 0.75 ADRA2A (0.79) CFBADRA2CADRA2AADRA2BHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020229526-A1 IMPROVED LYOPHILIZED FORMULATIONS INVOLVING HYALURONIC ACID AND PLASMATIC PROTEINS, AND USES THEREOF BONE THERAPEUTICS SA (BE) 2020-11-19 WO disclosed
EP-2900247-A1 FORMULATIONS INVOLVING SOLVENT/DETERGENT-TREATED PLASMA (S/D PLASMA) AND USES THEREOF Bone Therapeutics S.A. (BE) 2015-08-05 EP disclosed
WO-2013076160-A1 SUSTAINED RELEASE FORMULATIONS USEFUL IN THE TREATMENT OF DISEASES Université Libre de Bruxelles (BE) 2013-05-30 WO disclosed